Classifying Cytogenetics in Patients with Acute Myelogenous Leukemia in Complete Remission Undergoing Allogeneic Transplantation: A Center for International Blood and Marrow Transplant Research Study Philippe Armand, Haesook T. Kim, Mei-Jie Zhang, Waleska S. Perez, Paola S. Dal Cin, Thomas R. Klumpp, Edmund K. Waller, Mark R. Litzow, Jane L. Liesveld, Hillard M. Lazarus, Andrew S. Artz, Vikas Gupta, Bipin N. Savani, Philip L. McCarthy, Jean-Yves Cahn, Harry C. Schouten, Jürgen Finke, Edward D. Ball, Mahmoud D. Aljurf, Corey S. Cutler, Jacob M. Rowe, Joseph H. Antin, Luis M. Isola, Paolo Di Bartolomeo, Bruce M. Camitta, Alan M. Miller, Mitchell S. Cairo, Keith Stockerl-Goldstein, Jorge Sierra, M. Lynn Savoie, Joerg Halter, Patrick J. Stiff, Chadi Nabhan, Ann A. Jakubowski, Donald W. Bunjes, Effie W. Petersdorf, Steven M. Devine, Richard T. Maziarz, Martin Bornhauser, Victor A. Lewis, David I. Marks, Christopher N. Bredeson, Robert J. Soiffer, Daniel J. Weisdorf Biology of Blood and Marrow Transplantation Volume 18, Issue 2, Pages 280-288 (February 2012) DOI: 10.1016/j.bbmt.2011.07.024 Copyright © 2012 American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 1 Transplantation outcomes for patients classified by the CIBMTR grouping scheme. (A) OS. (B) LFS. (C) CIR. (D) Cumulative incidence of NRM. Biology of Blood and Marrow Transplantation 2012 18, 280-288DOI: (10.1016/j.bbmt.2011.07.024) Copyright © 2012 American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 2 OS of patients classified according to the CIBMTR schema, stratified by disease status. (A) Patients undergoing transplantation in CR1. (B) Patients undergoing transplantation in CR2. Biology of Blood and Marrow Transplantation 2012 18, 280-288DOI: (10.1016/j.bbmt.2011.07.024) Copyright © 2012 American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 3 OS of patients classified according to the CIBMTR schema, stratified by donor type. (A) Patients receiving an MRD transplant. (B) Patients receiving a URD transplant. Biology of Blood and Marrow Transplantation 2012 18, 280-288DOI: (10.1016/j.bbmt.2011.07.024) Copyright © 2012 American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 4 OS of patients classified according to the CIBMTR schema, stratified by conditioning intensity. (A) Patients undergoing transplantation with myeloablative conditioning. (B) Patients undergoing transplantation with RIC. Biology of Blood and Marrow Transplantation 2012 18, 280-288DOI: (10.1016/j.bbmt.2011.07.024) Copyright © 2012 American Society for Blood and Marrow Transplantation Terms and Conditions